prescription drugs
A quarter-century after the U.S. Food and Drug Administration approved the first prescription drugs based on the main psychoactive ingredient in marijuana, additional medicines derived from or inspired by the cannabis plant itself could soon be making their way to pharmacy shelves, according to drug companies, small biotech firms and university scientists.
FDA Revisits Safety of Newer Birth Control Drugs
2:35PM 12/05/2011
Birth control drugs that were heavily promoted as having fewer side effects are now under scrutiny from the FDA in the wake of new research suggesting that they are more likely to cause blood clots than older drugs.
What Not to Do When Filling a Prescription
6:00AM 10/27/2011
Cold and flu season is upon us. Americans spend $400 million on prescription drugs to relieve the symptoms, according to one study, and some of them spend too much. DailyFinance's Laura Rowley looks at what not to do when filling a prescription.
Breast Cancer's Financial Toll: The High Cost of Fighting for Your Life
11:00AM 10/05/2011
Breast cancer is the second most common cancer among American women: 12% will develop it at some point in their lives, and at that point, the health battle begins. But those women often must fight one a second front as well, dealing with the multiple threats cancer poses to their financial well-being.
How to Save on Health Insurance, Part 2: Individual Plans
1:00PM 9/28/2011
With the unemployment rate at almost 10% and companies cutting back on benefits, millions of people are responsible for securing their own health insurance. Picking the right plan for you can be tricky, so DailyFinance asked consumer health experts for tips on how to maximize benefits while minimizing costs.
Economic Woes Are Jeopardizing Americans' Health
12:00PM 9/28/2011
In this economy, people aren't just cutting out luxuries, nearly half of Americans are skimping on necessities like medication and doctor visits -- drastic actions that could be dangerous to their health.
The Dark Cloud Over Growing Antidepressant Prescriptions
4:00PM 8/10/2011
Health Care, Bristol-Myers Squibb, Eli Lilly, Astrazeneca, Consumer Ally
They call it the Great "Recession," but there's no question that these are depressing times. And doctors are writing scripts for antidepressants at an alarming rate -- especially given that many of these doctors aren't psychiatrists. What are the effects on patients who haven't been properly screened?
How to Make the Most of Medicare
12:00PM 8/03/2011
Simply the fact of no more paychecks can make retirement hard enough, but rising health care costs can really compound the difficulty of what should be your golden years. Fortunately there's help, in the form of Medicare -- in particular, Medicare Part D for prescription drugs. Here's what you need to know about this critical benefit, which can save you thousands of dollars a year.
CVS Caremark is best known for its drugstore busines. But it's also finding its way into the business of managing prescription-drug insurance claims. After taking some heat in the last few quarters, it is starting to see revenue from some big contracts in this segment.
Will Congress Cure the Problems with Health Care FSAs?
4:55PM 7/29/2011
You practically have to be an accountant to manage your family's health care these days. The good news is, some lawmakers seem to recognize this and are working toward changes to one program that should be well received by employers, employees and doctors alike.
More Stories
Next Page →Market Movers
| Symbol | Last | Change / % | Volume |
|---|
Most Actives
| 8.07 | -0.11 -1.34% | 254.23M | |
| 2.19 | +0.25 +12.89% | 122.18M | |
| 18.88 | -0.26 -1.33% | 109.55M | |
| 12.44 | -0.25 -1.97% | 52.49M |
% Gainers
| 31.68 | +7.78 +32.55% | 18.42M | |
| 89.96 | +13.57 +17.76% | 13.27M | |
| 2.19 | +0.25 +12.89% | 122.18M | |
| 10.50 | +1.10 +11.70% | 3.07M |
% Losers
DailyFinance Wire
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
- Why Used Car Bargains Are Getting Harder to Find
- 5 Reasons Facebook Stock May Be a Better Buy Than You Think
Newswire
- Greece's grim choice: deep budget cuts or...
- Greek premier defends bailout deal, painful...
- Faces beyond the numbers of long-term...
- Staff at The Sun tabloid arrested in bribe...
- Obama budget: New spending with recycled tax...
- Obama budget seeks to boost trade enforcement
- As Facebook IPO nears, the case for dull stocks
- Turbo-traders take Bank of America for a ride
- Getting paid $35,000 to short sell
- What the $26B settlement means for you
- Investing your emergency cash: Return vs. risk
- First Premier's $400-a-year credit card
- Big banks' bloated mortgage tab
- Fewer young adults hold jobs than ever before
- Government assistance expands
- Bob Rodriguez: The best advice I ever got
- 24/7 Wall St. Top Analyst Calls of the Week (AONE, ALU, AMSC, NLY, AAPL, CSCO, COH, CSTR, COP, DLR, IBM, LF, MMM, M, OPEN, POST, SIRI, SOHU, TRLG, ZOLT)
- The Force: Star Wars Franchise Worth Over $30 Billion and Growing
- 24/7 Wall St. Closing Bell (COP, GILD, AMSC, MA, COH, LNKD, ATVI, CPST, GPRE, KONA, TRLG, LGF, MOVE, NBL, PCYC, ALU, FLIR, RUTH, FSLR, CIE, TBAC, RPXC, AMRS)
- Mid-day Movers (CIE, AMRS, IPSU, MOVE, LNKD)
- Petrobras Shares Volatile on $225 Billion Development Plan (PBR)
- Morning Movers (CIE, ALU, LNKD, AMRS, XIDE)
- AEP Dividend Growth Still Looks Safe Ahead (AEP)
- Arch Coal Tumbles on Earnings, Forecast (ACI, ANR, PCX, BTU, CNX)
Follow Us
